Drug-drug Interaction Study With TS-142 in Healthy Adult Subjects (Concomitant Administration of Itraconazole)
Status:
Completed
Trial end date:
2020-11-14
Target enrollment:
Participant gender:
Summary
This is an open-label, single-center, single-sequence study to evaluate the concomitant
effects of the potent CYP3A inhibitor itraconazole on the single-dose pharmakokinetics,
safety and tolerability of oral TS-142 in healthy subjects.